연구용

Stattic STAT3 억제제

제품 번호S7024

최초의 비펩타이드성 저분자 화합물인 Stattic은 세포 없는 분석에서 5.1 μM의 IC50으로 STAT3 활성화 및 핵 전위를 강력하게 억제하며, STAT1에 비해 높은 선택성을 보인다. Stattic은 apoptosis를 유도한다.
Stattic STAT 억제제 Chemical Structure

화학 구조

분자량: 211.19

바로가기

품질 관리

배치: 순도: 99.88%
99.88

세포 배양, 처리 및 작업 농도

세포주 분석 유형 농도 배양 시간 제형 활성 설명 PMID
H9c2 Function Assay 10 μM 4 h reverses the effects of IL-27 26339633
NPC  Function Assay 0-7.5 µM abolishes EMT-like molecular alterations, and cell migration and invasion induced by RKIP knockdown 25915430
HASMC Function Assay 1.25-5 μM 20 min DMSO  inhibits p-(Y)-STAT-1,3,5 signals  25849622
H9c2  Function Assay 2/10 μM 2 h DMSO  abrogates the cytoprotective effects of IL-27 against SH 25820907
A431 Growth Inhibition Assay 2 μM 2 h blocks EGF-reversed decreases in cell viability 25720435
A431 Growth Inhibition Assay 2 μM 2 h increases in apoptosis induced by shikonin 25720435
SiHa Cell Viability Assay 5-75 nM 24 h  shows morphology of a typical apoptotic cell and dose-dependent loss of cell viability  25539644
SiHa Function Assay 5-75 nM 24 h  reduces the phosphorylation at the tyrosine residue 705  25539644
ECA109 Growth Inhibition Assay 0-20 μM 24 h  IC50=5.50 μM 25492480
TE13 Growth Inhibition Assay 0-20 μM 24 h  IC50=6.15 μM 25492480
KYSE150  Growth Inhibition Assay 0-20 μM 24 h  IC50=12.64 μM 25492480
ECA109 Clonogenic Survival Assay 0.5 μM 24 h  suppresses the clonogenic formation 25492480
TE13 Clonogenic Survival Assay 0.5 μM 24 h  suppresses the clonogenic formation 25492480
KYSE150  Clonogenic Survival Assay 0.5 μM 24 h  suppresses the clonogenic formation 25492480
ECA109 Function Assay 0.5 μM 24 h  enhances IR-induced generation of DSBs 25492480
PC3M-1E8 Function Assay 2.5/5/10 μM 0-4 h inhibits the STAT3 activation in a dose- and time-dependent manner  25261365
PC3M-1E8 Function Assay 10 μM 24 h downregulates Bcl-xL, survivin and c-Myc 25261365
PC3M-1E8 Function Assay 10 μM 24 h inhibits IL-6 induced STAT3 activation and the IL-6-induced STAT3 activation 25261365
PC3M-1E8 Clonogenic Survival Assay 2.5/5/10 μM inhibits the colony formation significantly 25261365
MDA-MB-231 Function Assay 20 μM 2 h exhibits Snail and E-cadherin expression 25153349
H9c2 Function Assay 20 µM 30 min DMSO  abolishes propofol-induced AKT phosphorylation at both ser473 and thr308 25105067
HaCaT  Growth Inhibition Assay 10 µM 20 min DMSO  enhances sorafenib- and sunitinib-induced growth inhibition 25013907
Caki-1 Growth Inhibition Assay 10 µM 20 min DMSO  enhances sorafenib- and sunitinib-induced growth inhibition 25013907
HaCaT  Apoptosis Assay 10 µM 20 min DMSO  increases proportions of apoptotic cells due to treatment with sorafenib or sunitinib 25013907
FHL-primed hNSCs Cell Viability Assay 0.02-5 μM 72 h leads to the loss of cell viability at high concentration 24945434
ELL-primed hNSCs Cell Viability Assay 0.02-5 μM 72 h leads to the loss of cell viability at high concentration 24945434
SS Cell Viability Assay 1-10 μM 72 h DMSO causes a dose-dependent inhibition of the viability  24756111
SeAx  Cell Viability Assay 1-10 μM 72 h DMSO causes a dose-dependent inhibition of the viability  24756111
HuT-78 Cell Viability Assay 1-10 μM 72 h DMSO causes a dose-dependent inhibition of the viability  24756111
CD4+ Apoptosis Assay 10 μm 24 h DMSO induces apoptosis strongly 24756111
MCF-7 Growth Inhibition Assay 0.469-3.75 μM 5 d reduces cell number significantly 24728078
MCF-7/LCC1 Growth Inhibition Assay 0.469-3.75 μM 5 d reduces cell number significantly 24728078
MCF-7/LCC9 Growth Inhibition Assay 0.469-3.75 μM 5 d reduces cell number significantly 24728078
HaCaT Growth Inhibition Assay 10 µM 20 min DMSO  enhances everolimus-induced cell growth inhibition 24423131
HaCaT Apoptosis Assay 10 µM 20 min DMSO  enhances the apoptotic effects of everolimus 24423131
MDA-MB-231 Function Assay 10 µM 24 h DMSO  reduces P-STAT3 expression 24376586
SUM-159 Function Assay 10 µM 24 h DMSO  reduces P-STAT3 expression 24376586
SK-BR-3 Function Assay 10 µM 24 h DMSO  reduces P-STAT3 expression 24376586
MCF7-HER2 Growth Inhibition Assay 0-10 μM 48 h DMSO induces cell death dose dependently 24297508
MCF7-HER2 Function Assay 5 μM 24 h DMSO diminishes Sox-2, Oct-4, and slug expression 24297508
MCF7-HER2 Function Assay 5 μM 24 h DMSO decreases the expression levels of EMT markers, vimentin and slug 24297508
MCF7-HER2 Growth Inhibition Assay 5 μM 24 h DMSO enhances cell growth inhibition combined with Herceptin 24297508
HMECs  Function Assay 10 μM 2 h inhibits IFNα mediated phosphorylation of STAT1, STAT2 and STAT3 24211327
HTR8/SVneo Function Assay 1 μM  1 h suppressed OSM-induced STAT3 phosphorylation 24060241
HTR8/SVneo Function Assay 0.5/1 μM  48 h restores the expression of E-cadherin suppressed by OSM 24060241
HTR8/SVneo Function Assay 1 μM  48 h significantly increases migration by OSM  24060241
C13* Apoptosis Assay 0-10 μM 24/48 h induces apoptosis in a dose and time dependent manner 23962558
OV2008 Apoptosis Assay 0-10 μM 24/48 h induces apoptosis in a dose and time dependent manner 23962558
C13* Apoptosis Assay 24/48 h enhances cisplatin-induced apoptosis 23962558
OV2008 Apoptosis Assay 24/48 h enhances cisplatin-induced apoptosis 23962558
W480  Function Assay 2.5/10 μM 30 min DMSO sensitizes cells to chemoradiotherapy in a dose-dependent manner 23934972
SW837 Function Assay 2.5/10 μM 30 min DMSO sensitizes cells to chemoradiotherapy in a dose-dependent manner 23934972
T24 Function Assay 2/10/20 μM 24 h causes dose-dependent inhibition of the CXCL12-induced increase of invading cells 23526079
CNE1 Function Assay 20 µM 48 h blocks the IL-6 increased phosphorylation of Stat3 23382914
CNE2 Function Assay 20 µM 48 h blocks the IL-6 increased phosphorylation of Stat3 23382914
HONE1 Function Assay 20 µM 48 h blocks the IL-6 increased phosphorylation of Stat3 23382914
CNE1 Growth Inhibition Assay 4 μM significantly reduces cell viability 23382914
CNE1 Function Assay 0-20 μM 0-4 h inhibits Stat3 activation in a dose- and time-dependent manner 23382914
CNE2 Function Assay 0-20 μM 0-4 h inhibits Stat3 activation in a dose- and time-dependent manner 23382914
HONE1 Function Assay 0-20 μM 0-4 h inhibits Stat3 activation in a dose- and time-dependent manner 23382914
CNE1 Cell Viability Assay 0.5-64 μM 48 h suppresses cell viability in a dose- and time-dependent manner 23382914
CNE2 Cell Viability Assay 0.5-64 μM 48 h suppresses cell viability in a dose- and time-dependent manner 23382914
HONE1 Cell Viability Assay 0.5-64 μM 48 h suppresses cell viability in a dose- and time-dependent manner 23382914
C666-1  Cell Viability Assay 0.5-64 μM 48 h suppresses cell viability in a dose- and time-dependent manner 23382914
CNE1 Apoptosis Assay 10 µM  48 h induces apoptosis  23382914
CNE2 Apoptosis Assay 10 µM  48 h induces apoptosis  23382914
HONE1 Apoptosis Assay 10 µM  48 h induces apoptosis  23382914
CNE2 Cell Viability Assay 1/2 μM 48 h sensitize cells to radiotherapy 23382914
HONE1 Cell Viability Assay 1/2 μM 48 h sensitize cells to radiotherapy 23382914
C666-1  Cell Viability Assay 1/2 μM 48 h sensitize cells to radiotherapy 23382914
HEC-1A Function Assay 1 μM  24 h DMSO blocks the MUC20-enhanced invasion triggered by 10% FBS 23262208
RL95-2 Function Assay 1 μM  24 h DMSO blocks the MUC20-enhanced invasion triggered by 10% FBS 23262208
HEC-1A Function Assay 1 μM  24 h DMSO blocks the MUC20-enhanced invasion triggered by EGF  23262208
RL95-2 Function Assay 1 μM  24 h DMSO blocks the MUC20-enhanced invasion triggered by EGF  23262208
CT26 Function Assay 20 mM 1 h suppresses HGF-induced VEGF expression  23233163
UM-SCC-17B Growth Inhibition Assay IC50=2.562 ± 0.409 μM, GI50=1.279 ± 0.194 μM 22770899
OSC-19 Growth Inhibition Assay IC50=3.481 ± 0.953 μM, GI50=1.366 ± 0.770 μM 22770899
Cal33 Growth Inhibition Assay IC50=2.282 ± 0.423 μM, GI50=1.349 ± 0.363 μM 22770899
UM-SCC-22B Growth Inhibition Assay IC50=2.648 ± 0.542 μM, GI50=1.320 ± 0.204 μM 22770899
UM-SCC-17B Function Assay 0-30 μM 0-24 h inhibits STAT3 activation dose and time dependently 22770899
OSC-19 Function Assay 0-30 μM 0-24 h inhibits STAT3 activation dose and time dependently 22770899
Cal33 Function Assay 0-30 μM 0-24 h inhibits STAT3 activation dose and time dependently 22770899
UM-SCC-22B Function Assay 0-30 μM 0-24 h inhibits STAT3 activation dose and time dependently 22770899
U-87MG Cell Viability Assay 0-10 μM 72 h DMSO inhibits cell viability dose dependently 25436682
U-373MG Cell Viability Assay 0-10 μM 72 h DMSO inhibits cell viability dose dependently 25436682
SH-SY5Y Cell Viability Assay 0-10 μM 72 h DMSO inhibits cell viability dose dependently 25436682
Tu-9648 Cell Viability Assay 0-10 μM 72 h DMSO inhibits cell viability dose dependently 25436682
Neuro-2a Cell Viability Assay 0-10 μM 72 h DMSO inhibits cell viability dose dependently 25436682
PCNs Cell Viability Assay 0-10 μM 72 h DMSO inhibits cell viability dose dependently 25436682
PGCs Cell Viability Assay 0-10 μM 72 h DMSO inhibits cell viability dose dependently 25436682
RAW264.7 Function Assay 10 μM 12 h abrogates the mRNA expressions of JAK2, STAT1, STAT2, and STAT3 induced by DON and T-2 toxin 22454431
RAW264.7 Apoptosis Assay 5/10 μM 45 min enhances toxins induced apoptosis and MMP loss 22454431
SW480 Cell Viability Assay 5/10/20 μM 72 h inhibits cell viability of the ALDH+/CD133+ cells 21900397
HCT116 Cell Viability Assay 5/10/20 μM 72 h inhibits cell viability of the ALDH+/CD133+ cells 21900397
DLD-1  Cell Viability Assay 5/10/20 μM 72 h inhibits cell viability of the ALDH+/CD133+ cells 21900397
SNU387  Cell Viability Assay 20 μM  24 h reduces cell viability 21311975
SNU398 Cell Viability Assay 20 μM  24 h reduces cell viability 21311975
HepG2 Cell Viability Assay 20 μM  24 h reduces cell viability 21311975
Huh-7 Cell Viability Assay 20 μM  24 h reduces cell viability 21311975
VSMC Growth Inhibition Assay 3/5/10 μM 30 min DMSO prevents PDGF- and thrombin-mediated VSMC proliferation in a dose-dependent manner 20847306
MDA-MB-231 Apoptosis Assay 10 μM 24 h DMSO  induces apoptosis 17114005
MDA-MB-435S Apoptosis Assay 10 μM 24 h DMSO  induces apoptosis 17114005
AsPC1 Antiproliferative assay 72 hrs Antiproliferative activity against human AsPC1 cells assessed as inhibition of cell proliferation after 72 hrs by MTS assay, IC50 = 1.32 μM. 24904966
MDA-MB-231 Antiproliferative assay 72 hrs Antiproliferative activity against ER-negative and triple-negative human MDA-MB-231 cells assessed as inhibition of cell proliferation after 72 hrs by MTS assay, IC50 = 2.89 μM. 24904966
MCF7 Antiproliferative assay 72 hrs Antiproliferative activity against ER-positive human MCF7 cells assessed as inhibition of cell proliferation after 72 hrs by MTS assay, IC50 = 3.6 μM. 24904966
PANC1 Antiproliferative assay 72 hrs Antiproliferative activity against human PANC1 cells assessed as inhibition of cell proliferation after 72 hrs by MTS assay, IC50 = 3.77 μM. 24904966
MDA-MB-231 Cytotoxicity assay 48 hrs Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 48 hrs by MTT assay, IC50 = 1.56 μM. 26396689
MDA-MB-435S Cytotoxicity assay 48 hrs Cytotoxicity against human MDA-MB-435S cells assessed as growth inhibition after 48 hrs by MTT assay, IC50 = 1.87 μM. 26396689
MCF7 Cytotoxicity assay 48 hrs Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay, IC50 = 2.16 μM. 26396689
A549 Cytotoxicity assay 48 hrs Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay, IC50 = 2.5 μM. 26396689
DU145 Cytotoxicity assay 48 hrs Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by MTT assay, IC50 = 2.5 μM. 26396689
PANC1 Cytotoxicity assay 48 hrs Cytotoxicity against human PANC1 cells assessed as growth inhibition after 48 hrs by MTT assay, IC50 = 2.9 μM. 26396689
HCT116 Antiproliferative assay 72 hrs Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, IC50 = 1.08 μM. 27718470
MDA-MB-231 Antiproliferative assay 72 hrs Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay, IC50 = 1.68 μM. 27718470
MCF7 Antiproliferative assay 72 hrs Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay, IC50 = 2.36 μM. 27718470
A549 Antiproliferative assay 72 hrs Antiproliferative activity against human A549 cells after 72 hrs by MTT assay, IC50 = 4.4 μM. 27718470
AD293 Function assay 6 hrs Inhibition of IFNgamma-stimulated GFP/FLAG-tagged STAT3 dimerization in human AD293 cells incubated for 6 hrs by Western blot analysis, IC50 = 5.1 μM. 30228000
MDA-MB-231 Function assay 1 to 10 uM 12 hrs Inhibition of STAT3 phosphorylation at Tyr705 in human MDA-MB-231 cells at 1 to 10 uM after 12 hrs by western blot analysis 24904966
MDA-MB-231 Anticancer assay 1 to 10 uM 48 hrs Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition, apoptosis and cellular morphological changes at 1 to 10 uM after 48 hrs by light microscopy 24904966
MDA-MB-231 Function assay 1 to 10 uM 12 hrs Decrease in STAT3 protein expression in human MDA-MB-231 cells at 1 to 10 uM after 12 hrs by western blot analysis 24904966
MCF7 Function assay 12 hrs Inhibition of STAT3 phosphorylation at Y705 in human MCF7 cells after 12 hrs by Western blot analysis 26396689
MDA-MB-435S Function assay 12 hrs Inhibition of STAT3 phosphorylation at Y705 in human MDA-MB-435S cells after 12 hrs by Western blot analysis 26396689
MDA-MB-231 Function assay 12 hrs Inhibition of STAT3 phosphorylation at Y705 in human MDA-MB-231 cells after 12 hrs by Western blot analysis 26396689
클릭하여 더 많은 세포주 실험 데이터 보기

화학 정보, 보관 및 안정성

분자량 211.19 화학식

C8H5NO4S

보관 (수령일로부터)
CAS 번호 19983-44-9 SDF 다운로드 원액 보관

동의어 N/A Smiles C1=CC(=CC2=C1C=CS2(=O)=O)[N+](=O)[O-]

용해도

In vitro
배치:

DMSO : 42 mg/mL (198.87 mM)
(수분으로 오염된 DMSO는 용해도를 감소시킬 수 있습니다. 신선하고 무수 DMSO를 사용하십시오.)

Water : Insoluble

Ethanol : Insoluble

몰농도 계산기

질량 농도 부피 분자량
희석 계산기 분자량 계산기

In vivo
배치:

생체 내 제형 계산기 (투명한 용액)

1단계: 아래 정보 입력 (권장: 실험 중 손실을 고려하여 추가 동물 포함)

mg/kg g μL

2단계: 생체 내 제형 입력 (이것은 계산기일 뿐 제형이 아닙니다. 용해도 섹션에 생체 내 제형이 없는 경우 먼저 당사에 문의하십시오.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

계산 결과:

작업 농도: mg/ml;

DMSO 원액 준비 방법: mg 약물 사전 용해 μL DMSO ( 원액 농도 mg/mL, 농도가 해당 약물 배치의 DMSO 용해도를 초과하는 경우 먼저 당사에 문의하십시오. )

생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가μL PEG300, 혼합하고 투명하게 한 다음 추가μL Tween 80, 혼합하고 투명하게 한 다음 추가 μL ddH2O, 혼합하고 투명하게 합니다.

생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가 μL 옥수수 기름, 혼합하고 투명하게 합니다.

참고: 1. 다음 용매를 추가하기 전에 액체가 투명한지 확인하십시오.
2. 용매를 순서대로 추가해야 합니다. 다음 용매를 추가하기 전에 이전 추가에서 얻은 용액이 투명한 용액인지 확인해야 합니다. 와동, 초음파 또는 뜨거운 물 중탕과 같은 물리적 방법을 사용하여 용해를 도울 수 있습니다.

작용 메커니즘

특징
Stattic is the first non-peptide small molecule with inhibitory activity against STAT3 SH2 domain regardless of the STAT3 phosphorylation state in vitro.
Targets/IC50/Ki
STAT3
(Cell-free assay)
5.1 μM
시험관 내(In vitro)

Stattic은 gp130 수용체에서 유래한 포스포티로신 함유 펩타이드가 STAT3 SH2 도메인에 결합하는 것을 강력한 온도 의존적인 방식으로 억제한다. 이 화합물은 티로신 인산화된 펩타이드가 티로신 키나아제 Lck의 SH2 도메인에 결합하는 데 매우 약한 영향만을 미친다. 그리고 다른 두 가지 이량체 전사 인자(c-Myc/Max 및 Jun/Jun)의 이량체화를 억제하지 않는다. 또한 플루오레세인 표지된 포스포펩타이드가 STAT1 및 STAT5b의 SH2 도메인에 결합하는 것을 억제한다. 이 화학물질은 10 μM 농도에서 STAT3 동종이량체의 DNA 결합을 선택적으로 억제한다. STAT3의 Tyr705에서의 세포 인산화를 억제하는 것으로 나타났으며, STAT1의 Tyr701에서의 인산화(HepG2 세포에서) 또는 JAK1, JAK2 및 c-Src의 인산화(MDA-MB-231 및 MDA-MB-235S 세포에서)에는 거의 영향을 미치지 않는다. 이 화합물은 STAT3 의존성 유방암 세포주의 아팝토시스 비율을 증가시킨다.

키나아제 분석
고속 스크리닝 및 형광 편광 분석
스크리닝은 약 30 °C에서 수행됩니다. 스크리닝 히트의 특이성은 STAT1, STAT5 및 Lck의 SH2 도메인에 대한 시험 화합물의 결합에 대한 유사 분석에서 검증됩니다. 모든 FP 분석에 사용되는 완충액 성분의 최종 농도는 10 mM HEPES (pH 7.5), 1 mM EDTA, 0.1% Nonidet P-40, 50 mM NaCl 및 10% DMSO입니다. Dithiothreitol의 부재는 억제 활성에 필수적입니다. 펩타이드 서열은 다음과 같습니다: STAT3, 5-carboxyfluorescein-GY(PO3H2)LPQTV-NH2; STAT1, 5-carboxyfluorescein-GY(PO3H2)DKPHVL; STAT5, 5-carboxyfluorescein-GY(PO3H2)LVLDKW; 및 Lck, 5-carboxyfluorescein-GY(PO3H2)EEIP. 30 °C에서의 특이성 분석을 위해 단백질은 150 nM (STAT1, STAT3 및 STAT5)으로 사용됩니다. 37 °C에서의 특이성 분석을 위해 단백질은 370 nM (STAT3) 또는 100 nM (Lck)으로 사용됩니다. 단백질은 에펜도르프 튜브에서 시험 화합물과 지정된 온도에서 60분 동안 배양한 후 해당 5-카르복시플루오레세인 표지된 펩타이드를 첨가합니다 (최종 농도: 10 nM). 실온에서 측정하기 전에 혼합물은 최소 30분 동안 평형을 이루도록 합니다. 시험 화합물은 DMSO에 20배 희석된 재고 용액에서 지정된 농도로 사용됩니다. 결합 곡선 및 억제 곡선은 SigmaPlot으로 피팅됩니다. 모든 경쟁 곡선은 독립적인 실험에서 세 번 반복됩니다.
참조

적용 분야

방법 바이오마커 이미지 PMID
Western blot p-STAT3 / STAT3 Survivin / c-Myc / Bcl-xl PARP / C-PARP / Caspase-3 / C-Caspse-3
S7024-WB1
25261365
Immunofluorescence p-STAT3 / STAT3 / Survivin
S7024-IF1
25261365
Growth inhibition assay Cell viability
S7024-viability1
23382914
ELISA BDNF
S7024-ELISA1
27456333

기술 지원

취급 설명서

Tel: +1-832-582-8158 Ext:3

다른 문의사항이 있으시면 메시지를 남겨주세요.

이름을 입력해주세요.
이메일을 입력해주세요. 유효한 이메일 주소를 입력해주세요.
저희에게 무엇이든 작성해주세요.